Literature DB >> 9030382

Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor.

M Murphy, D Armstrong, K A Sepkowitz, R N Ahkami, P L Myskowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9030382

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  10 in total

1.  Human Herpesvirus 8 Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

2.  Nelfinavir induces radiation sensitization in pituitary adenoma cells.

Authors:  Jing Zeng; Alfred P See; Khaled Aziz; Saravanan Thiyagarajan; Tarek Salih; Rajendra P Gajula; Michael Armour; Jillian Phallen; Stephanie Terezakis; Lawrence Kleinberg; Kristen Redmond; Russell K Hales; Roberto Salvatori; Alfredo Quinones-Hinojosa; Phuoc T Tran; Michael Lim
Journal:  Cancer Biol Ther       Date:  2011-10-01       Impact factor: 4.742

3.  Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients.

Authors:  G J van den Horn; C Meenken; S A Danner; P Reiss; M D de Smet
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

Review 4.  When Global ART Budgets Cannot Cover All Patients, Who Should Be Eligible?

Authors:  Yi Zhang; Till Bärnighausen; Nir Eyal
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

Review 5.  A risk-benefit assessment of HIV protease inhibitors.

Authors:  G J Moyle; B G Gazzard
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

Review 6.  A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.

Authors:  G Nasti; D Errante; S Santarossa; E Vaccher; U Tirelli
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

Review 7.  Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention.

Authors:  Soren Gantt; Corey Casper; Richard F Ambinder
Journal:  Curr Opin Oncol       Date:  2013-09       Impact factor: 3.645

8.  Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?

Authors:  Michael J Silverberg; Donald I Abrams
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

9.  Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.

Authors:  Mary Cianfrocca; Sandra Lee; Jamie Von Roenn; Anil Tulpule; Bruce J Dezube; David M Aboulafia; Richard F Ambinder; Jeannette Y Lee; Susan E Krown; Joseph A Sparano
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

10.  An APE1 inhibitor reveals critical roles of the redox function of APE1 in KSHV replication and pathogenic phenotypes.

Authors:  Canrong Zhong; Mengyang Xu; Yan Wang; Jun Xu; Yan Yuan
Journal:  PLoS Pathog       Date:  2017-04-05       Impact factor: 6.823
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.